Drug exposure: still an excellent biomarker. - Wikidata - wikimedia - TriplyDB

Drug exposure: still an excellent biomarker.

Drug exposure: still an excellent biomarker.

http://www.wikidata.org/entity/Q37755342

about

The Valley of Death in anticancer drug development: a reassessment Pharmacokinetically guided algorithm of 5-fluorouracil dosing, a reliable strategy of precision chemotherapy for solid tumors: a meta-analysis.

P2860

Q26861274-673B527D-0195-4E1B-B58D-DBED3DAF4294 Q42757426-75B56A51-5D46-4D5D-A2C1-946C6E7FFF6D

P2860

Drug exposure: still an excellent biomarker.

http://www.wikidata.org/entity/Q37755342

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on December 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Drug exposure: still an excellent biomarker.

@en

Drug exposure: still an excellent biomarker.

@nl

type

label

Drug exposure: still an excellent biomarker.

@en

Drug exposure: still an excellent biomarker.

@nl

prefLabel

Drug exposure: still an excellent biomarker.

@en

Drug exposure: still an excellent biomarker.

@nl

P1433

Q37755342-B8DDCA31-6FD2-4507-9077-C4E3751001A2

P1476

Q37755342-E6033FBA-6F5A-46C4-8430-5DAF14577ABD

P2093

Q37755342-8D6D4B49-81DC-4F6A-AE00-3FF3A43F63BE

Q37755342-F9D55429-9EBF-40C6-9D10-797BE6EB01DC

P2860

Q37755342-0561C115-B4BA-43E8-8BF5-6AFB798E8DB4

Q37755342-1281CDB3-0F81-48C6-BBBE-187CA93AAABE

Q37755342-31464075-CFA3-46E6-9C36-2AA11348EAC2

Q37755342-3AF9F4C5-753D-4C28-8D92-0A567DD85739

Q37755342-5128C413-19BB-4643-80EB-19BA840DB7AA

Q37755342-61EA0EE5-6171-4D1D-AFCC-5574D1938C52

Q37755342-817F49F5-7F3E-480D-8D9A-078FBB12D4EA

Q37755342-9320708D-61C1-4480-A4B0-355FA06E27C7

Q37755342-979D6E8E-13BD-40FE-B50B-8FAF9D6CF0AC

Q37755342-B297F0EE-CF5E-4A36-B625-262885DFC01C

P304

Q37755342-65080894-2142-43A2-AC91-B23FE33E02A4

P31

Q37755342-0A94DA33-3FF8-4005-BF9A-3166A7CB9393

P356

Q37755342-0F6A3CEF-E291-46B5-9151-D86271DC9B25

P433

Q37755342-9233C593-FA01-4905-8D18-65B02BDAA43F

P478

Q37755342-AD3599C9-2522-4CFE-9180-A91CFD7E4D2D

P577

Q37755342-09DC7D1B-EF94-4F72-A554-45B4A1EDE316

P698

Q37755342-55D12FAF-BC5B-4C64-A897-BE56EEDF2DD7

P921

Q37755342-740E696E-CCA8-4CEE-B68D-9F5DF6857BD4

P356

P1433

Biomarkers in Medicine

P1476

Drug exposure: still an excellent biomarker.

@en

P2093

Judith Meza-Junco

http://www.w3.org/2001/XMLSchema#string

Michael B Sawyer

http://www.w3.org/2001/XMLSchema#string

P2860

Biomarkers and surrogate endpoints: preferred definitions and conceptual framework

Relationships between carboplatin exposure and tumor response and toxicity in patients with ovarian cancer.

Carboplatin dosage: prospective evaluation of a simple formula based on renal function.

Application of the area under the curve of carboplatin in predicting toxicity and efficacy.

Adaptive control methods for the dose individualisation of anticancer agents.

Oral vinorelbine pharmacokinetics and absolute bioavailability study in patients with solid tumors.

Population pharmacokinetics and pharmacokinetic-pharmacodynamic relationships for docetaxel.

Individualised cancer chemotherapy: strategies and performance of prospective studies on therapeutic drug monitoring with dose adaptation: a review.

Individual fluorouracil dose adjustment based on pharmacokinetic follow-up compared with conventional dosage: results of a multicenter randomized trial of patients with metastatic colorectal cancer.

Overcoming CYP1A1/1A2 mediated induction of metabolism by escalating erlotinib dose in current smokers

P304

723-731

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/BMM.09.58

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P577

2009-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20477710

http://www.w3.org/2001/XMLSchema#string

P921